Lembo_Anthony_J_BOSTON_web.jpg Identify the dominant symptom in IBS Many patients with irritable bowel syndrome don’t seek care. When they do, discuss time lines and triggers. Identifying pancreatitis etiology may help prevent progression Potential etiology of acute pancreatitis in 2020 includes genetic factors, drugs, and comorbidities. Address root causes to manage NASH Treat underlying factors such as obesity and diabetes to reduce risk of liver disease progression. Bolster_Marcy_B_web.jpg Reassuring rheumatic disease patients on value of bisphosphonates Dr. Marcy B. Bolster addresses common patient concerns about bisphosphonate use. El%20Serag_Hasem_HOUSTON_web.jpg Hepatocellular carcinoma shows risk factor shift Demographics, obesity, and metabolic factors have emerged as main drivers of disease. Address root causes to manage NASH Treat underlying factors such as obesity and diabetes to reduce risk of liver disease progression. Vande_Casteele_Niels_CA_web.jpg Strategic approach mitigates impact of antidrug antibodies in patients with rheumatic diseases Consider dose escalation and adding an immunomodulator to overcome the impact of antidrug antibodies in rheumatic disease patients. Dr. Len Calabrese gives advice on vaccinating adult patients with rheumatic disease He highlights safety protocols and advises on recommended vaccines in rheumatology practice. Furie_Richard_A_NY_web.jpg Promising drugs line up for lupus treatment Lupus drugs in late-stage development seek to address unmet needs, notably in lupus nephritis. Stein_Gold_Linda_MICH_web.jpg Rosacea: Target treatment to pathogenic pathway LAHAINA, HAWAII – Papules and pustules, background erythema, telangiectasias, and phyma each need a tailored approach. Pages« first ‹ previous 1 2 3 4 5 6 7 8 9 … next › last »
